Sanofi Active Ingredient Solutions

About

Company description

CEPiA (Commercial & External Partnership, Industrial Affairs) is an organization within the Industrial Affairs of Sanofi fully dedicated to third parties. We offer API Contract Manufacturing & Custom Synthesis competences from small molecules to biologics, from lab scale to commercial quantities. Additionally, we offer our extensive drug product facilities.

Quick facts

Sales markets	Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity	Importer; Manufacturer; Service
Affiliated categories:	Generic APIs \|APIs \|Antibiotics More

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 16B50 Book a meeting See our Exhibitor Profile See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 60C21 See our Exhibitor Profile See full Exhibitor List

Our Top products

Dengvaxia®

Sanofi Aventis Group offers a wide range of products which includes dengvaxia®. It is the first ever vaccine against dengue fever. Contact us for more information.

More info

Praluent® (alirocumab)1

Sanofi Aventis Group offers a wide range of products which includes praluent® (alirocumab)1. It fight against hypercholesterolemia. Contact us for more information.

More info

Toujeo® (insulin glargine 300 u/ml)

Sanofi Aventis Group offers a wide range of products which includes toujeo® (insulin glargine 300 u/ml). It is used in diabetes. Contact us for more information.

More info

View all our products (146)